On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Roughly 80% of women will get human papillomavirus (HPV) in their lifetime. For many, especially those who have gotten an HPV vaccine, the virus will go away on its own within two years.

Form Health, a virtual obesity care provider, launched a new program on Tuesday to prevent the shift from overweight to obesity. Boston-based Form Health already offers an obesity program for ...

When Galapagos and Gilead Sciences entered a global drug R&D collaboration six years ago, the deal focused on Galapagos’s capabilities as a developer of small molecule drugs. Fast forward to ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.

When it comes to AI in healthcare, it’s common for people to feel uncertain. Patients wonder: Will AI change the way care feels? Will it affect the trust and connection I expect from providers?

The digital era is gradually taking over our institutional memory in healthcare. Every year, the next generation of physicians enters the workforce with no lived experience of a paper-based ...

Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by ...

Recent research shows almost half of U.S. counties don’t have a practicing cardiologist. The fact that more than 22 million Americans must travel nearly 90 miles round trip to seek this ...

San Francisco, CA – FusionCare.AI, a startup aimed at transforming comprehensive obesity and metabolic care, was unveiled today at the 4th Annual “Future and Health Executive Summit.” ...

Only in the crazy sector of metabolic medicines can 32% revenue growth be considered a disappointment. That’s how much Eli Lilly’s revenue grew in 2024, but it was still not as much as the ...